Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor - Esté,J.A.; Cabrera,C.; De Clercq,E.; Struyf,S.; Van Damme,J.; Bridger,G.; Skerlj,R.T.; Abrams,M.J.; Henson,G.; Gutierrez,A.; Clotet,B.; Schols,D. (Mol Pharmacol, 1999)